Nefazodone-induced carbamazepine toxicity.
Ashton
A K
AK
Wolin
R E
RE
D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy; D002220:Carbamazepine / Q000009:adverse effects* / Q000097:blood / Q000494:pharmacology; D051544:Cytochrome P-450 CYP3A; D065607:Cytochrome P-450 Enzyme Inhibitors; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D010879:Piperazines; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000494:pharmacology; D014230:Triazoles / Q000009:adverse effects* / Q000494:pharmacology
D002220:Carbamazepine; D051544:Cytochrome P-450 CYP3A; D065607:Cytochrome P-450 Enzyme Inhibitors; D006899:Mixed Function Oxygenases; D010879:Piperazines; D017367:Selective Serotonin Reuptake Inhibitors; D014230:Triazoles; C051752:nefazodone; C104464:CYP3A protein, human